News | June 03, 2022
LEO Pharma strengthens its commercial organization
The refocused commercial set-up will increase organizational efficiency and alignment across all commercial functions globally
The refocused commercial set-up will increase organizational efficiency and alignment across all commercial functions globally
Futnani has over two decades of experience in delivering growth and transformation that spans several therapeutic areas.
The proposed demerger is the most significant corporate change for GSK in the last 20 years
The product will be launched by NATCO's commercial partner Viatris.
Already an existing partner and supplier of ingredients to Medisca, striking this agreement with SUANFARMA involved reinforcing a well-established symbiotic relationship between two companies committed to world-class quality, service, and price
JB, in its new avatar, emerges as the fastest growing pharmaceuticals company in India
The Toradol tablets, 10 mg brand and generic had U.S. sales of approximately US $ 16.8 million MAT for the most recent twelve months ending in March 2022 according to IQVIA
The company will invest approximately €440 million to increase membrane manufacturing capacity in Carrigtwohill and to build a new manufacturing facility at Blarney Business Park, both in Cork, Ireland
According to IQVIA sales data for the 12-month period ending March 2022, the Zytiga tablets, 500 mg market achieved annual sales of approximately US $ 260.2 million
Leading pharma companies are achieving rapid, large-scale performance improvements using a multifaceted approach that realizes short-term gains & builds long-term capabilities at the same time
Subscribe To Our Newsletter & Stay Updated
